Brokerages Set Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Target Price at $44.00


Share on StockTwits

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has received an average rating of “Hold” from the nineteen analysts that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $44.00.

Several research analysts recently weighed in on the company. Truist lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Wednesday, February 24th. Morgan Stanley reaffirmed an “equal weight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, December 9th. The Goldman Sachs Group lowered Fresenius Medical Care AG & Co. KGaA from a “conviction-buy” rating to a “buy” rating in a research report on Wednesday, February 3rd. Stifel Nicolaus lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Monday, February 1st. Finally, Jefferies Financial Group lowered Fresenius Medical Care AG & Co. KGaA from a “hold” rating to an “underperform” rating in a research report on Monday, January 11th.

A number of large investors have recently added to or reduced their stakes in the business. First Trust Advisors LP purchased a new position in Fresenius Medical Care AG & Co. KGaA in the fourth quarter valued at about $54,044,000. Todd Asset Management LLC increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 18.0% during the fourth quarter. Todd Asset Management LLC now owns 511,088 shares of the company’s stock worth $21,240,000 after acquiring an additional 77,799 shares during the last quarter. Nuveen Asset Management LLC purchased a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the fourth quarter worth about $19,909,000. Teachers Retirement System of The State of Kentucky increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 24.8% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 336,900 shares of the company’s stock worth $14,001,000 after acquiring an additional 66,900 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the fourth quarter worth about $2,894,000. 1.60% of the stock is currently owned by institutional investors.

Shares of FMS stock traded up $0.10 during mid-day trading on Monday, hitting $37.15. 254,362 shares of the company’s stock were exchanged, compared to its average volume of 479,678. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of $33.32 and a fifty-two week high of $46.55. The stock has a 50-day simple moving average of $36.12 and a two-hundred day simple moving average of $39.88. The company has a quick ratio of 0.84, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The stock has a market cap of $21.76 billion, a price-to-earnings ratio of 14.74, a PEG ratio of 1.81 and a beta of 1.21.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its earnings results on Tuesday, February 23rd. The company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.06. The business had revenue of $5.25 billion for the quarter, compared to analyst estimates of $5.76 billion. Fresenius Medical Care AG & Co. KGaA had a return on equity of 10.62% and a net margin of 7.38%. As a group, analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.85 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Further Reading: Special Purpose Acquisition Company (SPAC)

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.